Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The complex relationship between multiple drug resistance and the tumor pH gradient: a review
Tomas Koltai
Cancer Drug Resistance (2022) Vol. 5, Iss. 2, pp. 277-303
Open Access | Times Cited: 16

Showing 16 citing articles:

Pluronic® triblock copolymer-based nanoformulations for cancer therapy: A 10-year overview
Karine Cappuccio de Castro, Julia Cedran Coco, Érica Mendes dos Santos, et al.
Journal of Controlled Release (2022) Vol. 353, pp. 802-822
Closed Access | Times Cited: 59
Recent advances in access to overcome cancer drug resistance by nanocarrier drug delivery system
Xiangyu Sun, Ping Zhao, Jierou Lin, et al.
Cancer Drug Resistance (2023) Vol. 6, Iss. 2, pp. 390-415
Open Access | Times Cited: 31
Drug Resistance in Hepatocellular Carcinoma: Theoretical Basis and Therapeutic Aspects
Ya-ruo Lei, Xian-lu He, Jun Li, et al.
Frontiers in Bioscience-Landmark (2024) Vol. 29, Iss. 2, pp. 52-52
Open Access | Times Cited: 9
Acetazolamide and human carbonic anhydrases: retrospect, review and discussion of an intimate relationship
Dimitrios Tsikas
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 39, Iss. 1
Open Access | Times Cited: 20
Emerging Role of Extracellular pH in Tumor Microenvironment as a Therapeutic Target for Cancer Immunotherapy
Md. Ataur Rahman, Mahesh Kumar Yadab, Meser M. Ali
Cells (2024) Vol. 13, Iss. 22, pp. 1924-1924
Open Access | Times Cited: 7
Biomaterial-Based Responsive Nanomedicines for Targeting Solid Tumor Microenvironments
Konstantinos Avgoustakis, Athina Angelopoulou
Pharmaceutics (2024) Vol. 16, Iss. 2, pp. 179-179
Open Access | Times Cited: 6
The Antifungal Potential of Niclosamide and Structurally Related Salicylanilides
Bernhard Biersack
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 5977-5977
Open Access | Times Cited: 6
Insights on the Role of Polyphenols in Combating Cancer Drug Resistance
Mohd Farhan
Biomedicines (2023) Vol. 11, Iss. 6, pp. 1709-1709
Open Access | Times Cited: 12
Supramolecular host-guest nanosystems for overcoming cancer drug resistance
Sha Wu, Miaomiao Yan, Minghao Liang, et al.
Cancer Drug Resistance (2023) Vol. 6, Iss. 4, pp. 805-27
Open Access | Times Cited: 12
Polyhydroxyalkanoates (PHAs) and its copolymer nanocarrier application in cancer treatment: An overview and challenges
Veena Paul, Shikha Pandhi, Dipendra Kumar Mahato, et al.
International Journal of Biological Macromolecules (2024) Vol. 277, pp. 134201-134201
Closed Access | Times Cited: 4
The dual role of autophagy in suppressing and promoting hepatocellular carcinoma
Wasnaa Hatif Mohammed, Ghassan M. Sulaiman, Mosleh M. Abomughaid, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 3
Synthesis, biochemical screening and in-silico investigations of arylsulfonamides bearing linear and cyclic tails
Laura De Luca, Federica Bucolo, Andrea Angeli, et al.
Bioorganic & Medicinal Chemistry Letters (2024), pp. 129962-129962
Closed Access
Tumor Tissue Acidosis as a Factor Determining the Malignant Phenotype and Tumor Resistance to Chemotherapy
V. A. Kobliakov
Cell and Tissue Biology (2024) Vol. 18, Iss. 5, pp. 489-502
Closed Access
Targeting breast tumor extracellular matrix and stroma utilizing nanoparticles
Faris Anad Muhammad, Farag M. A. Altalbawy, Viralkumar Mandaliya, et al.
Clinical & Translational Oncology (2024)
Closed Access
Cancer stem cells in drug resistance: an introduction to the e-book covering the special issue on the “Cancer Stem Cells and Drug Resistance”
Balázs Sarkadi
Cancer Drug Resistance (2023) Vol. 6, pp. 239-41
Open Access | Times Cited: 1
Screening Campaign and Docking Investigations in Identifying New Hit Compounds as Inhibitors of Human Carbonic Anhydrases Expressed In Tumour Cells
Federico Ricci, Andrea Angeli, Francesca Mancuso, et al.
ChemMedChem (2023) Vol. 18, Iss. 20
Open Access | Times Cited: 1
Page 1

Scroll to top